Evoke Pharma (EVOK) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts EVOK Hot Sheet
Join SI Premium – FREE
Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
- Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
